Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies

Manuscript Number: 

17-1145R1

Author(s): 
David Ames, Prita R. Asih, Anna M. Barron, Prashant R. Bharadwaj, Belinda Brown, Samantha C. Burnham, Ashley I. Bush, Pratishtha Chatterjee, James D. Doecke, Kathryn A. Ellis, W.M.A.D. Binosha Fernando, Paul E. Fraser, Shaun Frost, Stephanie J. Fuller, Sam Gandy, Samantha L. Gardener, Kathryn Goozee, Sunil Gupta, Veer Gupta, Eugene Hone, Simon M. Laws, Wei Ling F. Lim, Ian J. Martins, Ralph N. Martins, Colin L. Masters, Sid E. O’Bryant, Steve Pedrini, Stephanie R. Rainey-Smith, Alan Rembach, Christopher C. Rowe, Olivier Salvado, Tejal Shah, Hamid R. Sohrabi, Kevin Taddei, Giuseppe Verdile, Victor L. Villemagne, Eka J. Wahjoepramono

Disclosures

David Ames

  • Nothing to Disclose

Prita R. Asih

  • Nothing to Disclose

Anna M. Barron

  • Nothing to Disclose

Prashant R. Bharadwaj

  • Nothing to Disclose

Belinda Brown

  • Nothing to Disclose

Samantha C. Burnham

  • Lecture Fees:
    Spoke at a clinical seminar for Novartis, lecture fee paid to my employer
    Patents/Royalties
    Method for detection of a neurological disease SC Burnham, N Faux, SM Laws US Patent App. 14/116,114

Ashley I. Bush

  • Consulting Fees:
    Collaborative Medicinal Development LLC
    Equity:
    Holds equity: Prana Biotechnology Ltd, Cogstate Ltd, Mesoblast Ltd, Brighton Biotech LLC, Grunbiotics Pty Ltd, Eucalyptus Pty Ltd Profit share: Collaborative Medicinal Development LLC.

Pratishtha Chatterjee

  • Nothing to Disclose

James D. Doecke

  • Nothing to Disclose

Kathryn A. Ellis

  • Nothing to Disclose

W.M.A.D. Binosha Fernando

  • Nothing to Disclose

Paul E. Fraser

  • Nothing to Disclose

Shaun Frost

  • Nothing to Disclose

Stephanie J. Fuller

  • Nothing to Disclose

Samantha L. Gardener

  • Nothing to Disclose

Kathryn Goozee

  • Nothing to Disclose

Sunil Gupta

  • Nothing to Disclose

Veer Gupta

  • Nothing to Disclose

Eugene Hone

  • Nothing to Disclose

Simon M. Laws

  • Nothing to Disclose

Wei Ling F. Lim

  • Nothing to Disclose

Ralph N. Martins

  • Nothing to Disclose

Ian J. Martins

  • Nothing to Disclose

Colin L. Masters

  • Nothing to Disclose

Sid E. O’Bryant

  • Nothing to Disclose

Steve Pedrini

  • Nothing to Disclose

Stephanie R. Rainey-Smith

  • Nothing to Disclose

Alan Rembach

  • Nothing to Disclose

Christopher C. Rowe

  • Lecture Fees:
    Biogen speaker fee GE Healthcare speaker fee
    Grants
    • Agency: 
      Piramal Imaging
      Dates: 
      2016-2018
    • Agency: 
      Cerveau/Enigma
      Dates: 
      2017-2018
    • Agency: 
      Biogen
      Dates: 
      2015-2018
    • Agency: 
      Astra Zeneca
      Dates: 
      2014-2017

Olivier Salvado

  • Nothing to Disclose

Tejal Shah

  • Nothing to Disclose

Hamid R. Sohrabi

  • Sponsors:
    I am the Western Australia Site Lead Neuropsychologist of Australian Alzheimer's Research Foundation for TOMM40 Study by Takeda Pharmaceuticals

Kevin Taddei

  • Nothing to Disclose

Giuseppe Verdile

  • Nothing to Disclose

Victor L. Villemagne

  • Consulting Fees:
    Lundbeck, Hoffman-La Roche, GE Heathcare, Shanghai Green Valley Pharmaceutical Co., Ltd, Abbvie
    Lecture Fees:
    GE Heathcare, Piramal Imaging, Lilly Healthcare

Eka J. Wahjoepramono

  • Nothing to Disclose

Sam Gandy

  • Disclosure not yet completed